Peptide amphiphile nanoparticles enhance the immune response against a CpG-adjuvanted influenza antigen.
Cationic peptide amphiphile nanoparticles are employed for co-delivery of immune modulator CpG and antigen. This results in better targeting to the antigen presenting cells and eliciting strong Th1 response, which is effective against the intracellular pathogens.